Combining an Autophagy Inhibitor, MPT0L145, with Abemaciclib Is a New Therapeutic Strategy in GBM Treatment

SIMPLE SUMMARY: Glioblastoma multiforme is a common and lethal malignant brain tumor, and occurrence of therapeutic resistance in GBM often causes relapse. Therefore, this study aimed to find a new therapeutic strategy to treat these malignant tumors. In the current study, combined abemaciclib with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Tsung-Han, Liang, Muh-Lii, Zheng, Jia-Huei, Lin, Yu-Chen, Yang, Yu-Chen, Vo, Thanh-Hoa, Liou, Jing-Ping, Yen, Yun, Chen, Chun-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656550/
https://www.ncbi.nlm.nih.gov/pubmed/34885226
http://dx.doi.org/10.3390/cancers13236117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656550/
https://www.ncbi.nlm.nih.gov/pubmed/34885226
http://dx.doi.org/10.3390/cancers13236117

Ejemplares similares